p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons

p53, initially considered a tumor suppressor, has been the subject of research related to cancer treatment resistance in the last 30 years. The unfavorable response to multimodal therapy and the higher recurrence rate, despite an aggressive approach, make HNSCC a research topic of interest for impro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mireștean, Camil Ciprian, Iancu, Roxana Irina, Iancu, Dragoș Petru Teodor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777383/
https://www.ncbi.nlm.nih.gov/pubmed/36553058
http://dx.doi.org/10.3390/diagnostics12123052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777383/
https://www.ncbi.nlm.nih.gov/pubmed/36553058
http://dx.doi.org/10.3390/diagnostics12123052

Ejemplares similares